Ontology highlight
ABSTRACT: Background
Tomato and soy intake is associated with reduced prostate cancer risk or severity in epidemiologic and experimental studies.Objective
On the basis of the principle that multiple bioactives in tomato and soy may act on diverse anticancer pathways, we developed and characterized a tomato-soy juice for clinical trials. In this phase 2 dose-escalating study, we examined plasma, prostate, and urine biomarkers of carotenoid and isoflavone exposure.Methods
Men scheduled for prostatectomy were recruited to consume 0, 1, or 2 cans of tomato-soy juice/d before surgery (mean ± SD duration: 24 ± 4.6 d). The juice provided 20.6 mg lycopene and 66 mg isoflavone aglycone equivalents/177-mL can. Plasma carotenoids and urinary isoflavone metabolites were quantified by HPL
SUBMITTER: Grainger EM
PROVIDER: S-EPMC6351139 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature